JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1989; 14:150-154
© 1989 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oshima, S
Right arrow Articles by Miyagi, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oshima, S
Right arrow Articles by Miyagi, H

Increased plasma fibrinopeptide A levels during attacks induced by hyperventilation in patients with coronary vasospastic angina

S Oshima, H Ogawa, H Yasue, K Okumura, K Matsuyama, and H Miyagi

Division of Cardiology, Kumamoto University Medical School, Japan.

Plasma fibrinopeptide A levels, beta-thromboglobulin levels and platelet factor 4 levels were estimated by enzyme-linked immunosorbent assay before and after hyperventilation in 12 patients with coronary vasospastic angina and in 12 control subjects matched for age and gender. In all 12 study patients, anginal attacks accompanied by electrocardiographic (ECG) changes (ST elevation in 11 patients and ST depression in 1 patient) were induced by hyperventilation. Coronary angiography was performed on 11 of the 12 patients, and coronary artery spasm with the same ECG changes was induced by intracoronary injection of acetylcholine in all 11. The plasma fibrinopeptide A levels increased significantly from 2.0 +/- 0.4 to 10.0 +/- 2.4 ng/ml during the attack (p less than 0.001) in the study patients, but remained unchanged before and after hyperventilation in the control subjects. The plasma levels of beta-thromboglobulin and platelet factor 4 remained unchanged after hyperventilation in both groups. Our data indicate that coronary artery spasm may induce thrombin generation and trigger thrombus formation in the coronary artery.


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
A. Tun and I. A. Khan
Myocardial Infarction with Normal Coronary Arteries: The Pathologic and Clinical Perspectives
Angiology, May 1, 2001; 52(5): 299 - 304.
[Abstract] [PDF]


Home page
QJMHome page
F. De Lorenzo, A. Noorani, and V.V. Kakkar
Current trends in the management of thromboembolic events
QJM, April 1, 2001; 94(4): 179 - 185.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. Ogawa, H. Soejima, K. Takazoe, S. Miyamoto, I. Kajiwara, H. Shimomura, T. Sakamoto, M. Yoshimura, K. Kugiyama, M. Kimura, et al.
Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina
Angiology, March 1, 2001; 52(3): 167 - 174.
[Abstract] [PDF]


Home page
CirculationHome page
L. M. Biasucci, G. Liuzzo, G. Caligiuri, G. Quaranta, F. Andreotti, G. Sperti, W. van de Greef, A. G. Rebuzzi, C. Kluft, and A. Maseri
Temporal Relation Between Ischemic Episodes and Activation of the Coagulation System in Unstable Angina
Circulation, June 15, 1996; 93(12): 2121 - 2127.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Kaikita, H. Ogawa, H. Yasue, T. Sakamoto, H. Suefuji, H. Sumida, and K. Okumura
Soluble P-Selectin Is Released Into the Coronary Circulation After Coronary Spasm
Circulation, October 1, 1995; 92(7): 1726 - 1730.
[Abstract] [Full Text]


Home page
CLIN APPL THROMB HEMOSTHome page
J. Amiral
State-of-the-Art Review: Usefulness of Laboratory Techniques for Evaluating Antithrombotic Efficacy of New Therapeutic Strategies
Clinical and Applied Thrombosis/Hemostasis, September 1, 1995; 1(4): 243 - 259.
[Abstract] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1989 by the American College of Cardiology Foundation.